Table 5.

Annualized percentage of patients who received an ACEI, according to Cr category and whether they were seen by a nephrologista

Cr CategoryAnnualized Percentage
All PatientsPatients Seen by NephrologistbPatients Not Seen by Nephrologist
aSee text for explanation. ACEI, angiotensin-converting enzyme inhibitor.
bSeen by a nephrologist within 1 yr after entry into the CKD cohort.
All patientsn = 1658n = 317n = 1341
all (n = 1658)0.340.310.35
<2.0 mg/dl (n = 1203)0.360.380.36
2.0 to 2.9 mg/dl (n = 289)0.310.310.31
3.0 to 3.9 mg/dl (n = 53)0.430.420.45
≥4.0 mg/dl (n = 113)0.150.160.09
Diabetic patientsn = 425n = 109n = 316
all (n = 425)0.490.440.51
<2.0 mg/dl (n = 287)0.500.560.50
2.0 to 2.9 mg/dl (n = 75)0.590.570.60
3.0 to 3.9 mg/dl (n = 20)0.450.430.56
≥4.0 mg/dl (n = 43)0.280.280.29
Nondiabetic patientsn = 1233n = 208n = 1025
all (n = 1233)0.290.240.30
<2.0 mg/dl (n = 916)0.320.320.32
2.0 to 2.9 mg/dl (n = 214)0.210.190.22
3.0 to 3.9 mg/dl (n = 33)0.410.410.41
≥4.0 mg/dl (n = 70)0.050.050.06